{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:19Z","timestamp":1792806019533,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01DA046234"],"award-info":[{"award-number":["K01DA046234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI117970"],"award-info":[{"award-number":["AI117970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bloomberg American Health Initiative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Experiencing a nonfatal overdose (NFOD) is a significant risk factor for a subsequent nonfatal or fatal overdose. Overdose mortality rates in rural Appalachian states are some of the highest in the USA, but little is known about correlates of overdose among rural populations of people who inject drugs (PWID). Our study aimed to identify correlates of experiencing a recent (past 6\u00a0months) NFOD among rural PWID in Cabell County, West Virginia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from a June\u2013July 2018 cross-sectional survey that was designed to estimate the size and characteristics of the PWID population in Cabell County, West Virginia, we used log binomial regression to identify correlates (e.g., structural vulnerabilities and substance use) of NFOD in the past 6\u00a0months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The majority of our sample of 420 PWID were male (61.2%), White, non-Hispanic (83.6%), and reported recent heroin injection (81.0%). More than two-fifths (42.6%) experienced a recent NFOD. Independent correlates of NFOD included witnessing an overdose in the past 6\u00a0months (adjusted prevalence ratio [aPR]\u2009=\u20092.28; 95% CI 1.48\u20133.50), attempting to quit using drugs in the past 6\u00a0months (aPR\u2009=\u20091.54; 95% CI 1.11\u20132.14), and the number of drugs injected (aPR\u2009=\u20091.16; 95% CI 1.10\u20131.23)<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A large proportion of rural PWID in Appalachia reported having recently overdosed. The associations between witnessing an overdose, attempting to quit using drugs, and number of drugs injected with recent nonfatal overdose underscore the need for expanded access to overdose prevention resources that are tailored to the needs of this population. Expanding access to evidence-based overdose prevention strategies\u2014such as take-home naloxone programs, treatment with methadone or buprenorphine, and harm reduction services\u2014may decrease overdose morbidity and mortality among rural PWID in Appalachia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-021-00470-y","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T05:05:29Z","timestamp":1613797529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Correlates of recent nonfatal overdose among people who inject drugs in West Virginia"],"prefix":"10.1186","volume":"18","author":[{"given":"N. Jia","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-3824","authenticated-orcid":false,"given":"Sean T.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Hamilton","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Perdue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Babcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Kilkenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"issue":"10159","key":"470_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","journal-title":"Lancet"},{"issue":"20","key":"470_CR2","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1001\/jama.2019.16932","volume":"322","author":"SH Woolf","year":"2019","unstructured":"Woolf SH, Schoomaker H. Life expectancy and mortality rates in the United States, 1959\u20132017. JAMA. 2019;322(20):1996\u20132016.","journal-title":"JAMA"},{"issue":"11","key":"470_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and opioid-involved overdose deaths\u2014United States, 2017\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"2","key":"470_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2105\/AJPH.2018.304845","volume":"109","author":"S Warfield","year":"2019","unstructured":"Warfield S, Pollini R, Stokes CM, Bossarte R. Opioid-related outcomes in West Virginia, 2008\u20132016. Am J Public Health. 2019;109(2):303\u20135.","journal-title":"Am J Public Health"},{"key":"470_CR5","unstructured":"NIDA. West Virginia Opioid Summary. 2020."},{"issue":"12","key":"470_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1473-3099(16)30325-5","volume":"16","author":"L Degenhardt","year":"2016","unstructured":"Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(12):1385\u201398.","journal-title":"Lancet Infect Dis"},{"key":"470_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2019.07.030","volume":"73","author":"S Colledge","year":"2019","unstructured":"Colledge S, Peacock A, Leung J, Larney S, Grebely J, Hickman M, et al. The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis. Int J Drug Policy. 2019;73:172\u201384.","journal-title":"Int J Drug Policy"},{"key":"470_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","volume":"162","author":"A Caudarella","year":"2016","unstructured":"Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"10208","key":"470_CR9","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560\u201379.","journal-title":"Lancet"},{"key":"470_CR10","unstructured":"Zibbell J HJ, Clark SD, Ferrell A, Karon SL. Non-fatal opioid overdose and associated health outcomes: final summary report. 2019."},{"issue":"8","key":"470_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1360-0443.2001.96811135.x","volume":"96","author":"M Warner-Smith","year":"2001","unstructured":"Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction. 2001;96(8):1113\u201325.","journal-title":"Addiction"},{"issue":"8","key":"470_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1046\/j.1360-0443.2002.00132.x","volume":"97","author":"M Warner-Smith","year":"2002","unstructured":"Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction. 2002;97(8):963\u20137.","journal-title":"Addiction"},{"issue":"5","key":"470_CR13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.15288\/jsad.2011.72.774","volume":"72","author":"AM White","year":"2011","unstructured":"White AM, Hingson RW, Pan IJ, Yi HY. Hospitalizations for alcohol and drug overdoses in young adults ages 18\u201324 in the United States, 1999\u20132008: results from the nationwide inpatient sample. J Stud Alcohol Drugs. 2011;72(5):774\u201386.","journal-title":"J Stud Alcohol Drugs"},{"key":"470_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","volume":"46","author":"JJ Carroll","year":"2017","unstructured":"Carroll JJ, Marshall BDL, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study. Int J Drug Policy. 2017;46:136\u201345.","journal-title":"Int J Drug Policy"},{"key":"470_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","volume":"190","author":"KW Tupper","year":"2018","unstructured":"Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242\u20135.","journal-title":"Drug Alcohol Depend"},{"key":"470_CR16","first-page":"1","volume":"294","author":"H Hedegaard","year":"2017","unstructured":"Hedegaard H, Warner M, Minino AM. Drug overdose deaths in the United States, 1999\u20132016. NCHS Data Brief. 2017;294:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"3","key":"470_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/08897077.2019.1675115","volume":"41","author":"LN Pizzicato","year":"2020","unstructured":"Pizzicato LN, Johnson CC, Viner KM. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia. Pennsylvania Subst Abus. 2020;41(3):301\u20136.","journal-title":"Pennsylvania Subst Abus"},{"issue":"2","key":"470_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugalcdep.2005.10.015","volume":"83","author":"RA Pollini","year":"2006","unstructured":"Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006;83(2):104\u201310.","journal-title":"Drug Alcohol Depend"},{"key":"470_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.drugpo.2018.03.026","volume":"57","author":"K Hunter","year":"2018","unstructured":"Hunter K, Park JN, Allen ST, Chaulk P, Frost T, Weir BW, et al. Safe and unsafe spaces: non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City. Int J Drug Policy. 2018;57:25\u201331.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"470_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/10826084.2018.1491051","volume":"54","author":"B Wallace","year":"2019","unstructured":"Wallace B, Kennedy MC, Kerr T, Pauly B. Factors associated with nonfatal overdose during a public health emergency. Substance Use Misuse. 2019;54(1):39\u201345.","journal-title":"Substance Use Misuse"},{"issue":"1","key":"470_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12954-018-0240-z","volume":"15","author":"JN Park","year":"2018","unstructured":"Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm reduction journal. 2018;15(1):34.","journal-title":"Harm reduction journal"},{"issue":"3","key":"470_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.drugalcdep.2013.04.007","volume":"132","author":"R Pabayo","year":"2013","unstructured":"Pabayo R, Alcantara C, Kawachi I, Wood E, Kerr T. The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting. Drug Alcohol Depend. 2013;132(3):603\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"470_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drugalcdep.2019.03.026","volume":"201","author":"KE Schneider","year":"2019","unstructured":"Schneider KE, Park JN, Allen ST, Weir BW, Sherman SG. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: a latent class analysis. Drug Alcohol Depend. 2019;201:71\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"470_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1080\/09540121.2010.516346","volume":"23","author":"JR Havens","year":"2011","unstructured":"Havens JR, Oser CB, Leukefeld CG. Injection risk behaviors among rural drug users: implications for HIV prevention. AIDS Care. 2011;23(5):638\u201345.","journal-title":"AIDS Care"},{"issue":"48","key":"470_CR25","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 3","key":"470_CR26","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.2105\/AJPH.2014.302520","volume":"105","author":"M Faul","year":"2015","unstructured":"Faul M, Dailey MW, Sugerman DE, Sasser SM, Levy B, Paulozzi LJ. Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities. Am J Public Health. 2015;105(Suppl 3):e26\u201332.","journal-title":"Am J Public Health."},{"issue":"31","key":"470_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.15585\/mmwr.mm6831e1","volume":"68","author":"GP Guy Jr","year":"2019","unstructured":"Guy GP Jr, Haegerich TM, Evans ME, Losby JL, Young R, Jones CM. Vital signs: pharmacy-based naloxone dispensing\u2014United States, 2012\u20132018. MMWR Morb Mortal Wkly Rep. 2019;68(31):679\u201386.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"470_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.12307","volume":"35","author":"CHA Andrilla","year":"2019","unstructured":"Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update. J Rural Health. 2019;35(1):108\u201312.","journal-title":"J Rural Health"},{"issue":"1","key":"470_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-019-0305-7","volume":"16","author":"ST Allen","year":"2019","unstructured":"Allen ST, Grieb SM, O\u2019Rourke A, Yoder R, Planchet E, White RH, et al. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16(1):33.","journal-title":"Harm Reduct J"},{"key":"470_CR30","doi-asserted-by":"publisher","first-page":"107581","DOI":"10.1016\/j.drugalcdep.2019.107581","volume":"204","author":"ST Allen","year":"2019","unstructured":"Allen ST, White RH, O\u2019Rourke A, Grieb SM, Kilkenny ME, Sherman SG. Take-home naloxone possession among people who inject drugs in rural West Virginia. Drug Alcohol Depend. 2019;204:107581.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"470_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2105\/AJPH.2018.304873","volume":"109","author":"ST Allen","year":"2019","unstructured":"Allen ST, O\u2019Rourke A, White RH, Schneider KE, Kilkenny M, Sherman SG. Estimating the number of people who inject drugs in a rural county in Appalachia. Am J Public Health. 2019;109(3):445\u201350.","journal-title":"Am J Public Health"},{"issue":"2","key":"470_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10461-015-1085-z","volume":"20","author":"MS Ruiz","year":"2016","unstructured":"Ruiz MS, O\u2019Rourke A, Allen ST. Using capture-recapture methods to estimate the population of people who inject drugs in Washington. DC AIDS Behav. 2016;20(2):363\u20138.","journal-title":"DC AIDS Behav"},{"issue":"12","key":"470_CR33","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/j.1365-3156.2010.02654.x","volume":"15","author":"B Vuylsteke","year":"2010","unstructured":"Vuylsteke B, Vandenhoudt H, Langat L, Semde G, Menten J, Odongo F, et al. Capture-recapture for estimating the size of the female sex worker population in three cities in Cote d\u2019Ivoire and in Kisumu, Western Kenya. Trop Med Int Health. 2010;15(12):1537\u201343.","journal-title":"Trop Med Int Health"},{"issue":"12","key":"470_CR34","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1046\/j.1360-0443.2000.951217959.x","volume":"95","author":"G Hay","year":"2000","unstructured":"Hay G. Capture-recapture estimates of drug misuse in urban and non-urban settings in the north east of Scotland. Addiction. 2000;95(12):1795\u2013803.","journal-title":"Addiction"},{"issue":"11","key":"470_CR35","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/0956462414555931","volume":"26","author":"M Mutagoma","year":"2015","unstructured":"Mutagoma M, Kayitesi C, Gwiza A, Ruton H, Koleros A, Gupta N, et al. Estimation of the size of the female sex worker population in Rwanda using three different methods. Int J STD AIDS. 2015;26(11):810\u20134.","journal-title":"Int J STD AIDS"},{"issue":"5","key":"470_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-2435.2011.00715.x","volume":"53","author":"SJ Gold","year":"2015","unstructured":"Gold SJ, Wibert WN, Bondartsova V, Biroscak BJ, Post LA. A capture\u2013recapture approach to estimation of refugee populations. Int Migr. 2015;53(5):3\u201325.","journal-title":"Int Migr"},{"key":"470_CR37","unstructured":"Allen ST, O'Rourke A, White RH, Schneider KE, Hazelett T, Kilkenny M, et al. Rural communities in crisis: a critical count to save lives during the opioid epidemic: Bloomberg American Health Initiative; 2019. https:\/\/americanhealth.jhu.edu\/RuralOpioidsCount."},{"key":"470_CR38","unstructured":"UNAIDS\/WHO Working Group on Global HIV\/AIDS and STI Survelliance. Guidelines on estimating the size of populations most at risk to HIV. 2010:51."},{"key":"470_CR39","unstructured":"US Census Bureau. 2010 census urban and rural classification and urban area criteria."},{"issue":"3","key":"470_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/10550887.2011.581989","volume":"30","author":"SP Novak","year":"2011","unstructured":"Novak SP, Kral AH. Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine users in the United States. J Addict Dis. 2011;30(3):248\u201357.","journal-title":"J Addict Dis"},{"issue":"33","key":"470_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","volume":"65","author":"RM Gladden","year":"2016","unstructured":"Gladden RM, Martinez P, Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths\u201427 states, 2013\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65(33):837\u201343.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"470_CR42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","volume":"68","author":"RM Gladden","year":"2019","unstructured":"Gladden RM, O\u2019Donnell J, Mattson CL, Seth P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine\u201425 states, July\u2013December 2017 to January\u2013June 2018. MMWR Morb Mortal Wkly Rep. 2019;68(34):737\u201344.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"470_CR43","doi-asserted-by":"publisher","first-page":"e192851","DOI":"10.1001\/jamanetworkopen.2019.2851","volume":"2","author":"L LaRue","year":"2019","unstructured":"LaRue L, Twillman RK, Dawson E, Whitley P, Frasco MA, Huskey A, et al. Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine. JAMA Netw Open. 2019;2(4):e192851.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"470_CR44","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11606-018-4817-8","volume":"34","author":"N Koyawala","year":"2019","unstructured":"Koyawala N, Landis R, Barry CL, Stein BD, Saloner B. Changes in outpatient services and medication use following a non-fatal opioid overdose in the West Virginia Medicaid Program. J Gen Intern Med. 2019;34(6):789\u201391.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"470_CR45","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1080\/10826084.2020.1753773","volume":"55","author":"ST Allen","year":"2020","unstructured":"Allen ST, O\u2019Rourke A, White RH, Sherman SG, Grieb SM. Perspectives on fentanyl test strip use among people who inject drugs in rural Appalachia. Subst Use Misuse. 2020;55(10):1594\u2013600.","journal-title":"Subst Use Misuse"},{"key":"470_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-7517-4-14","volume":"4","author":"MM Islam","year":"2007","unstructured":"Islam MM, Conigrave KM. Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduct J. 2007;4:14.","journal-title":"Harm Reduct J"},{"issue":"1","key":"470_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000253858","volume":"16","author":"D Otiashvili","year":"2010","unstructured":"Otiashvili D, Zabransky T, Kirtadze I, Piralishvili G, Chavchanidze M, Miovsky M. Why Do the clients of georgian needle exchange programmes inject buprenorphine? Eur Addict Res. 2010;16(1):1\u20138.","journal-title":"Eur Addict Res"},{"issue":"5","key":"470_CR48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/dar.12397","volume":"35","author":"CA Day","year":"2016","unstructured":"Day CA, White B, Haber PS. The impact of an automatic syringe dispensing machine in inner-city Sydney, Australia: no evidence of a \u201choney-pot\u201d effect. Drug Alcohol Rev. 2016;35(5):637\u201343.","journal-title":"Drug Alcohol Rev"},{"key":"470_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-7517-11-16","volume":"11","author":"C Duplessy","year":"2014","unstructured":"Duplessy C, Reynaud EG. Long-term survey of a syringe-dispensing machine needle exchange program: answering public concerns. Harm Reduct J. 2014;11:16.","journal-title":"Harm Reduct J"},{"issue":"12","key":"470_CR50","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.2105\/AJPH.89.12.1852","volume":"89","author":"Y Obadia","year":"1999","unstructured":"Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machines for injection drug users: an experiment in Marseille. France Am J Public Health. 1999;89(12):1852\u20134.","journal-title":"France Am J Public Health"},{"key":"470_CR51","doi-asserted-by":"publisher","first-page":"100288","DOI":"10.1016\/j.sste.2019.100288","volume":"30","author":"O Amram","year":"2019","unstructured":"Amram O, Soc\u00edas E, Nosova E, Kerr T, Wood E, DeBeck K, et al. Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: a spatial analysis. Spat Spatio-temporal Epidemiol. 2019;30:100288.","journal-title":"Spat Spatio-temporal Epidemiol"},{"key":"470_CR52","doi-asserted-by":"publisher","first-page":"102722","DOI":"10.1016\/j.drugpo.2020.102722","volume":"79","author":"RG Carlson","year":"2020","unstructured":"Carlson RG, Daniulaityte R, Silverstein SM, Nahhas RW, Martins SS. Unintentional drug overdose: is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose? Int J Drug Policy. 2020;79:102722.","journal-title":"Int J Drug Policy"},{"key":"470_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drugalcdep.2019.03.009","volume":"200","author":"BE Payne","year":"2019","unstructured":"Payne BE, Klein JW, Simon CB, James JR, Jackson SL, Merrill JO, et al. Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program. Drug Alcohol Depend. 2019;200:71\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"470_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","volume":"103","author":"N Krawczyk","year":"2019","unstructured":"Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D. Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: addressing a critical care gap. J Subst Abuse Treat. 2019;103:1\u20138.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"470_CR55","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/08897077.2019.1635557","volume":"41","author":"JE Hood","year":"2020","unstructured":"Hood JE, Banta-Green CJ, Duchin JS, Breuner J, Dell W, Finegood B, et al. Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: lessons learned from Seattle. Washington Subst Abus. 2020;41(3):356\u201364.","journal-title":"Washington Subst Abus"},{"key":"470_CR56","unstructured":"CDC. Syringe Services Programs (SSPs) Fact Sheet Atlanta, GA: Centers for Disease Control and Prevention; 2019. https:\/\/www.cdc.gov\/ssp\/syringe-services-programs-factsheet.html."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-021-00470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-021-00470-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-021-00470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T05:13:01Z","timestamp":1613797981000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-021-00470-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1186\/s12954-021-00470-y","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants were verbally consented. This study was approved by the Johns Hopkins Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}